Dietary fiber intake is protective against overweight and obesity; however, a significant fiber gap exists between consumption and recommended intake values. Soluble fiber beneficially impacts metabolism, and supplementation may be a feasible approach to improve body composition and glycemia in overweight and obese individuals. The investigators will evaluate results of randomized controlled trials (RCTs) of soluble fiber supplementation among overweight and obese adults for outcomes related to weight management (e.g. body mass index \[BMI\], body weight, body fat percentage, waist circumference) and glucose and insulin homeostasis (e.g. fasting glucose, homeostasis model assessment of insulin resistance \[HOMA-IR\], fasting insulin) through systematic review and meta-analysis.
Study Type
OBSERVATIONAL
Enrollment
609
Participants receiving soluble fiber.
Participants receiving placebo.
University of Illinois, Urbana-Champaign
Urbana, Illinois, United States
Body mass index (kg/m2)
Time frame: ≥ 1 week
Body weight (kg)
Time frame: ≥ 1 week
Body fat (% fat mass)
Time frame: ≥ 1 week
Waist circumference (cm)
Time frame: ≥ 1 week
Fasting glucose (mmol/l)
Time frame: ≥ 1 week
Fasting insulin (pmol/l)
Time frame: ≥ 1 week
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
Time frame: ≥ 1 week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.